EKSO (Ekso Bionics Holdings, Inc.) Stock Financials & Earnings

EKSOEkso Bionics Holdings, Inc.

Mkt Cap$29M

Revenue (TTM)$13M

Net Income (TTM)-$12M

EPS (TTM)-$3.46

Free Cash Flow (TTM)-$12M

Gross Margin53.5%

Op. Margin-104.1%

Net Margin-91.4%

FCF Margin-92.2%

P/S Ratio (TTM)2.3x

P/E Ratio (TTM)—

YoY Rev Growth-28.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$4M	$2M	-$4M
Q2 23	$5M	$2M	-$4M
Q3 23	$5M	$2M	-$3M
Q4 23	$5M	$2M	-$3M
Q1 24	$4M	$2M	-$3M
Q2 24	$5M	$3M	-$2M
Q3 24	$4M	$2M	-$3M
Q4 24	$5M	$3M	-$2M
Q1 25	$3M	$2M	-$3M
Q2 25	$2M	$819K	-$4M
Q3 25	$4M	$3M	-$1M
Q4 25	$3M	$2M	-$5M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$1M	$3M	$2M
Q2 23	$1M	$3M	$2M
Q3 23	$1M	$2M	$2M
Q4 23	$1M	$3M	$2M
Q1 24	$1M	$2M	$2M
Q2 24	$1M	$2M	$2M
Q3 24	$777K	$2M	$2M
Q4 24	$845K	$2M	$2M
Q1 25	$988K	$3M	$2M
Q2 25	$852K	$2M	$2M
Q3 25	$550K	$2M	$1M
Q4 25	$641K	$3M	$2M

Revenue Segments

Quarter	Ekso Health	Ekso Works	Product	Product and Service, Other	Service	Subscription
Q1 23	$4M	$125K	—	—	—	—
Q3 23	—	—	$4M	$56K	$726K	$245K
Q1 24	—	—	$3M	$94K	$765K	$144K
Q2 24	—	—	$4M	$153K	$836K	$146K
Q3 24	—	—	$3M	$195K	$691K	$123K

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$16M	$0	$16M
Q2 23	$13M	$0	$13M
Q3 23	$10M	$0	$10M
Q4 23	$9M	$0	$9M
Q1 24	$9M	$0	$9M
Q2 24	$6M	$0	$6M
Q3 24	$8M	$0	$8M
Q4 24	$6M	$0	$6M
Q1 25	$8M	$0	$8M
Q2 25	$5M	$0	$5M
Q3 25	$3M	$0	$3M
Q4 25	$1M	$0	$1M

Shares Outstanding

Revenue Per Employee

Revenue / Employee